Comparision of glargine insulin and Regular insulin on quality of perioperative glucose control

Comparision of glargine insulin and Regular insulin on quality of perioperative glucose control in type2 diabetic patient undergoing viterectomy under general anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141127020112N8

Enrollment

Registered

2018-12-27

Start date

2017-08-11

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Patients received Glargine insulin (2/3 of the total dose of insulin) during surgery. Intervention 2: Control group: Patients received Regular insulin (Unit=glucose

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age: 30-70 years old Duration of diabetes for more than three months New York Heart Association (NYHA) class 1 or 2

Exclusion criteria

Exclusion criteria: Diabetic ketoacidosis or its history Renal failure Liver failure Hypoglycemia episodes in a hospital Hyperglycemia without a history of diabetes Pregnancy Patients or psychiatric disorders that can not provide information Corticosteroid use Infection and sepsis BMI more than 35

Design outcomes

Primary

Measure	Time frame
Blood Glucose. Timepoint: Every 45 minutes during surgery. Method of measurement: Glucometry.	—

Secondary

Measure	Time frame
Blood potassium. Timepoint: 2 and 4 hours after surgery. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPooya Derakhshan

Iran University of Medical Sciences

pooyaderak@yahoo.com+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026